Early Use of Sotrovimab in Children: A Case Report of an 11-Year-Old Kidney Transplant Recipient Infected with SARS-CoV-2

Early Use of Sotrovimab in Children: A Case Report of an 11-Year-Old Kidney Transplant Recipient Infected with SARS-CoV-2

Background: The use of virus-neutralizing monoclonal antibodies has been approved in fragile populations, including kidney transplant recipients, who are at risk of developing severe COVID-19. Sotrovimab is the only currently available anti-SARS-CoV-2 neutralizing monoclonal antibody with activity a...

Full description

Bibliographic Details
Main Authors: Costanza Di Chiara, Daniele Mengato, Marica De Pieri, Germana Longo, Elisa Benetti, Francesca Venturini, Carlo Giaquinto, Daniele Donà
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Children
Subjects:
sotrovimab
children
viral-neutralizing monoclonal antibodies
off-label
SARS-CoV-2
COVID-19
Online Access:https://www.mdpi.com/2227-9067/9/4/451

Internet

https://www.mdpi.com/2227-9067/9/4/451

Similar Items